Ardent Health Partners, LLC(ARDT)Earnings, Financials & Key Ratios

ARDT•NYSE

$9.37

$1.34B mkt cap·9.8× P/E·Price updated May 6, 2026

SectorHealthcare IndustryHealthcare Facilities Sub-IndustryHospitals and inpatient facilities

AboutArdent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.Show more

Revenue$6.32B+6.0%
EBITDA$481M-12.8%
Net Income$136M-35.4%
EPS (Diluted)0.96-39.2%
Gross Margin97.54%+18.0%
EBITDA Margin7.61%-17.8%
Operating Margin5.15%-24.3%
Net Margin2.15%-39.1%
ROE8.47%-47.6%
ROIC7.53%-22.2%
Debt/Equity1.34-10.4%
Interest Coverage5.90-9.8%

Technical→

ARDT Key Insights

Ardent Health Partners, LLC (ARDT) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓High quality earnings: Operating CF exceeds net income
✓Strong 5Y sales CAGR of 16.1%
✓Trading at only 0.8x book value
✓Efficient asset utilization: 1.2x turnover

✗Weaknesses

✗Thin 5Y average net margin of 1.4%
✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

ARDT Price & Volume

Ardent Health Partners, LLC (ARDT) stock price & volume — 10-year historical chart

Loading chart...

ARDT Growth Metrics

Ardent Health Partners, LLC (ARDT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years16.07%

3 Years7.23%

TTM6.72%

Profit CAGR

10 Years-

5 Years-

3 Years-10.42%

TTM-40.24%

EPS CAGR

10 Years-

5 Years-

3 Years-10.07%

TTM-42.07%

Return on Capital

10 Years8.36%

5 Years7.61%

3 Years7.84%

Last Year7.89%

ARDT Recent Earnings

Ardent Health Partners, LLC (ARDT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 6/12 qtrs (75%)●Beat Revenue 5/12 qtrs (63%)

Q2 2026Latest

May 5, 2026

EPS

$0.28

Est $0.18

+55.6%

Revenue

$1.6B

Est $1.6B

+1.5%

Q2 2026

Mar 4, 2026

EPS

$0.32

Est $0.35

-8.0%

Revenue

$1.6B

Est $1.6B

-1.6%

Q4 2025

Nov 12, 2025

EPS

$0.52

Est $0.42

+22.6%

Revenue

$1.6B

Est $1.5B

+1.8%

Q3 2025

Aug 5, 2025

EPS

$0.52

Est $0.30

+73.3%

Revenue

$1.6B

Est $1.6B

+0.7%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 5, 2026	$0.28vs $0.18+55.6%	$1.6Bvs $1.6B+1.5%
Q2 2026	Mar 4, 2026	$0.32vs $0.35-8.0%	$1.6Bvs $1.6B-1.6%
Q4 2025	Nov 12, 2025	$0.52vs $0.42+22.6%	$1.6Bvs $1.5B+1.8%
Q3 2025	Aug 5, 2025	$0.52vs $0.30+73.3%	$1.6Bvs $1.6B+0.7%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
HCAHCA Healthcare, Inc.Direct Competitor	96.01B	429.45	15.13	7.08%	8.97%
THCTenet Healthcare CorporationDirect Competitor	17.04B	194.51	12.56	3.12%	7.94%	19.56%	1.47
CYHCommunity Health Systems, Inc.Direct Competitor	404.47M	2.87	0.76	-1.18%	-0.41%
UHSUniversal Health Services, Inc.Direct Competitor	10.55B	168.49	7.29	9.71%	8.56%	20.65%	0.74
ENSGThe Ensign Group, Inc.Product Competitor	10.28B	175.93	30.13	18.72%	6.89%	16.61%	1.86
SEMSelect Medical Holdings CorporationProduct Competitor	2.04B	16.43	13.92	5.12%	2.42%	6.57%	1.82
ACHCAcadia Healthcare Company, Inc.Product Competitor	2.33B	25.30	-2.08	5.04%	-32.84%	-40.92%	1.24
SGRYSurgery Partners, Inc.Product Competitor	1.89B	14.59	-23.92	6.24%	-2.28%	-2.39%	1.14

Compare ARDT vs Peers

Ardent Health Partners, LLC (ARDT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HCA

Most directly comparable listed peer for ARDT.

Scale Benchmark

vs UNH

Larger-name benchmark to compare ARDT against a more recognizable public peer.

Peer Set

Compare Top 5

vs HCA, THC, CYH, UHS

ARDT Income Statement

Ardent Health Partners, LLC (ARDT) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'16	Dec'17	Dec'18	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	2.11B	3B	4.16B	5.13B	5.41B	5.97B	6.32B	6.43B
Revenue Growth %	-	42.6%	38.63%	23.25%	5.45%	10.29%	6.01%	6.72%
Cost of Goods Sold	0	0	0	955.17M	140.84M	1.03B	155.7M	2.54B
COGS % of Revenue	-	-	-	18.62%	2.6%	17.32%	2.46%	-
Gross Profit	2.11B▲ 0%	3B▲ 42.6%	4.16B▲ 38.6%	4.17B▲ 0.3%	5.27B▲ 26.2%	4.93B▼ 6.4%	6.17B▲ 25.0%	3.89B▲ 0%
Gross Margin %	100%	100%	100%	81.38%	97.4%	82.68%	97.54%	60.52%
Gross Profit Growth %	-	42.6%	38.63%	0.3%	26.21%	-6.37%	25.05%	-
Operating Expenses	2.11B	2.77B	4.08B	3.96B	5.04B	4.53B	5.84B	3.32B
OpEx % of Revenue	100%	92.35%	97.93%	77.15%	93.15%	75.88%	92.39%	-
Selling, General & Admin	1.95B	1.17B	2.68B	3.37B	3.62B	3.88B	1.19B	2.37B
SG&A % of Revenue	92.58%	38.86%	64.34%	65.73%	66.97%	65.11%	18.86%	-
Research & Development	0	19.9M	15.7M	0	0	0	0	0
R&D % of Revenue	-	0.66%	0.38%	-	-	-	-	-
Other Operating Expenses	0	0	0	585.81M	1.42B	642.51M	4.65B	3M
Operating Income	84.75M▲ 0%	121.77M▲ 43.7%	149.76M▲ 23.0%	217.03M▲ 44.9%	229.5M▲ 5.7%	405.76M▲ 76.8%	325.58M▼ 19.8%	570.95M▲ 0%
Operating Margin %	4.03%	4.06%	3.6%	4.23%	4.24%	6.8%	5.15%	8.88%
Operating Income Growth %	-	43.68%	22.98%	44.92%	5.75%	76.8%	-19.76%	-
EBITDA	156.27M	231.3M	292.95M	355.2M	370.35M	552.05M	481.29M	733.44M
EBITDA Margin %	7.42%	7.7%	7.04%	6.92%	6.85%	9.25%	7.61%	11.41%
EBITDA Growth %	-	48.02%	26.65%	21.25%	4.26%	49.06%	-12.82%	58.07%
D&A (Non-Cash Add-back)	71.51M	109.53M	143.19M	138.17M	140.84M	146.29M	155.7M	162.49M
EBIT	71.32M	121.38M	101.68M	393.53M	209.15M	428.64M	325.58M	338.84M
Net Interest Income	-26.95M	-70.74M	-108.59M	-82.05M	-65.42M	-65.58M	-55.2M	-41.03M
Interest Income	0	0	0	0	0	0	0	0
Interest Expense	26.95M	70.74M	108.59M	82.05M	65.42M	65.58M	55.2M	53.24M
Other Income/Expense	-40.38M	-71.13M	-264.37M	94.45M	-77.89M	-42.7M	-39.23M	-284.2M
Pretax Income	44.37M▲ 0%	50.64M▲ 14.1%	-114.62M▼ 326.3%	311.48M▲ 371.8%	151.61M▼ 51.3%	363.06M▲ 139.5%	286.36M▼ 21.1%	286.75M▲ 0%
Pretax Margin %	2.11%	1.69%	-2.75%	6.07%	2.8%	6.09%	4.53%	4.46%
Income Tax	8.02M	49.87M	-11.29M	46.11M	22.64M	63.35M	56.22M	57.09M
Effective Tax Rate %	18.08%	98.47%	9.85%	14.8%	14.93%	17.45%	19.63%	19.91%
Net Income	14.6M▲ 0%	-35.65M▼ 344.1%	-143.02M▼ 301.2%	188.91M▲ 232.1%	50.29M▼ 73.4%	210.34M▲ 318.2%	135.81M▼ 35.4%	134.28M▲ 0%
Net Margin %	0.69%	-1.19%	-3.44%	3.68%	0.93%	3.53%	2.15%	2.09%
Net Income Growth %	-	-344.15%	-301.21%	232.08%	-73.38%	318.24%	-35.43%	-40.24%
Net Income (Continuing)	36.35M	774K	-103.33M	265.37M	128.98M	299.71M	230.13M	229.66M
Discontinued Operations	0	0	0	0	0	0	0	0
Minority Interest	129.47M	382.55M	380.19M	411.26M	411.42M	390.98M	-1.25M	-3.76M
EPS (Diluted)	0.10▲ 0%	-0.25▼ 350.0%	-1.01▼ 304.0%	1.32▲ 230.7%	0.35▼ 73.5%	1.58▲ 351.4%	0.96▼ 39.2%	0.95▲ 0%
EPS Growth %	-	-350%	-304%	230.69%	-73.48%	351.43%	-39.24%	-42.07%
EPS (Basic)	0.10	-0.25	-1.01	1.32	0.35	1.59	0.96	-
Diluted Shares Outstanding	140.96M	140.96M	140.96M	143.26M	143.26M	132.75M	141.45M	141.78M
Basic Shares Outstanding	140.96M	140.96M	140.96M	143.26M	143.26M	132.44M	140.76M	141.27M
Dividend Payout Ratio	-	-	-	92.54%	-	-	-	-

ARDT Balance Sheet

Ardent Health Partners, LLC (ARDT) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'16	Dec'17	Dec'18	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	471.15M	736.42M	860.42M	1.41B	1.62B	1.83B	2.06B	2.02B
Cash & Short-Term Investments	92.61M	71.96M	59.66M	456.12M	437.58M	556.78M	709.6M	609.69M
Cash Only	92.61M	71.96M	59.66M	456.12M	437.58M	556.78M	709.6M	609.69M
Short-Term Investments	0	0	0	0	0	0	0	0
Accounts Receivable	261.04M	453.85M	529.12M	611.96M	785.76M	743.03M	686.1M	685.99M
Days Sales Outstanding	45.26	55.18	46.4	43.54	53.02	45.46	39.6	41.49
Inventory	47.09M	84.16M	84.81M	107.15M	105.48M	115.09M	118.59M	119.84M
Days Inventory Outstanding	-	-	-	40.95	273.37	40.66	278.01	17.2
Other Current Assets	31.08M	66.82M	100.57M	165.05M	211.99M	304.09M	544.53M	604.63M
Total Non-Current Assets	614.21M	1.64B	1.89B	3.45B	3.48B	3.12B	3.23B	3.23B
Property, Plant & Equipment	256.53M	591.57M	839.89M	1.99B	2.01B	2.04B	2.14B	2.14B
Fixed Asset Turnover	8.21x	5.07x	4.96x	2.58x	2.69x	2.93x	2.95x	3.04x
Goodwill	244.49M	818.19M	822.03M	844.7M	844.7M	852.08M	879.45M	879.26M
Intangible Assets	71.78M	78.26M	77.83M	76.93M	76.93M	76.93M	89.33M	88.34M
Long-Term Investments	0	0	0	29.4M	17.8M	11.46M	0	0
Other Non-Current Assets	37.76M	62.83M	50.11M	93.98M	129.31M	131.5M	111.69M	469.16M
Total Assets	1.09B▲ 0%	2.37B▲ 118.8%	2.75B▲ 15.7%	4.86B▲ 77.0%	5.1B▲ 5.0%	4.96B▼ 2.9%	5.29B▲ 6.7%	5.25B▲ 0%
Asset Turnover	1.94x	1.26x	1.52x	1.06x	1.06x	1.20x	1.20x	1.24x
Asset Growth %	-	118.78%	15.66%	76.96%	5%	-2.87%	6.74%	30.16%
Total Current Liabilities	328.14M	507.35M	624.83M	808.6M	994.1M	945.42M	1.05B	951.48M
Accounts Payable	131.94M	226.48M	230.36M	320.8M	474.54M	401.25M	457.94M	419.72M
Days Payables Outstanding	-	-	-	122.59	1.23K	141.76	1.07K	58.39
Short-Term Debt	7.67M	16.88M	8.96M	58.42M	61.03M	9.23M	23.44M	37.63M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0
Other Current Liabilities	39.98M	56.7M	190.75M	167.84M	172.82M	44.66M	565.16M	494.13M
Current Ratio	1.44x	1.45x	1.38x	1.74x	1.63x	1.94x	1.97x	1.97x
Quick Ratio	1.29x	1.29x	1.24x	1.61x	1.52x	1.82x	1.85x	1.85x
Cash Conversion Cycle	-	-	-	-38.1	-903.42	-55.64	-755.89	0.3
Total Non-Current Liabilities	361.22M	1.11B	1.41B	3B	3.03B	2.49B	2.56B	2.57B
Long-Term Debt	232.7M	935.81M	1.25B	1.15B	1.15B	1.07B	1.08B	1.18B
Capital Lease Obligations	0	0	0	1.18B	1.18B	1.16B	1.17B	3.49B
Deferred Tax Liabilities	0	0	0	381.03M	371.21M	0	0	0
Other Non-Current Liabilities	128.51M	171.09M	157.7M	290.01M	319.55M	261.75M	317.69M	2.29B
Total Liabilities	689.36M	1.61B	2.03B	3.81B	4.02B	3.43B	3.61B	3.52B
Total Debt	240.37M	952.69M	1.26B	2.39B	2.4B	2.28B	2.26B	1.21B
Net Debt	147.76M	880.73M	1.2B	1.93B	1.96B	1.73B	1.55B	603.27M
Debt / Equity	0.61x	1.25x	1.77x	2.27x	2.21x	1.50x	1.34x	1.34x
Debt / EBITDA	1.54x	4.12x	4.30x	6.72x	6.47x	4.13x	4.71x	1.65x
Net Debt / EBITDA	0.95x	3.81x	4.10x	5.44x	5.29x	3.13x	3.23x	3.23x
Interest Coverage	2.65x	1.72x	0.94x	4.80x	3.20x	6.54x	5.90x	6.36x
Total Equity	396.01M▲ 0%	760.28M▲ 92.0%	711.84M▼ 6.4%	1.05B▲ 47.5%	1.08B▲ 3.0%	1.52B▲ 40.7%	1.68B▲ 10.7%	1.73B▲ 0%
Equity Growth %	-	91.99%	-6.37%	47.55%	3.05%	40.66%	10.68%	80.61%
Book Value per Share	2.81	5.39	5.05	7.33	7.55	11.47	11.91	12.21
Total Shareholders' Equity	266.54M	377.72M	331.64M	639.05M	670.9M	1.13B	1.69B	1.73B
Common Stock	255.03M	401.86M	504.69M	510.97M	496.88M	1.43M	1.43M	1.43M
Retained Earnings	11.51M	-24.14M	-167.16M	101.55M	155.45M	365.8M	501.61M	541.46M
Treasury Stock	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	-5.89M	26.53M	18.56M	9.74M	-3.61M	-2.45M
Minority Interest	129.47M	382.55M	380.19M	411.26M	411.42M	390.98M	-1.25M	-3.76M

ARDT Cash Flow Statement

Ardent Health Partners, LLC (ARDT) cash flow — operating, investing & free cash flow history

Line item	Dec'16	Dec'17	Dec'18	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	85.78M	119.47M	159.59M	-38.36M	221.7M	315.03M	470.51M	470.51M
Operating CF Margin %	4.07%	3.98%	3.83%	-0.75%	4.1%	5.28%	7.44%	-
Operating CF Growth %	-	39.28%	33.58%	-124.04%	677.96%	42.1%	49.36%	6.86%
Net Income	14.6M	-35.65M	-143.02M	265.37M	128.98M	299.71M	230.13M	134.28M
Depreciation & Amortization	71.51M	109.53M	143.19M	138.17M	140.84M	146.29M	155.7M	162.49M
Stock-Based Compensation	0	0	0	611K	904K	17.98M	39.29M	29.29M
Deferred Taxes	-12.71M	49.7M	-7.82M	46.12M	4M	24.04M	43.59M	16.39M
Other Non-Cash Items	43.08M	45.83M	152.7M	-478.89M	3.29M	8.76M	5.13M	72.36M
Working Capital Changes	-30.71M	-49.94M	14.54M	-9.74M	-56.31M	-181.75M	-3.34M	-35.97M
Change in Receivables	-17.72M	-63.82M	-9.05M	-17.18M	-181.1M	40M	59.16M	89.9M
Change in Inventory	56K	-3.61M	-1.03M	4.67M	1.67M	-9.41M	-3.15M	799K
Change in Payables	-9.28M	41.3M	37.15M	14.42M	136.82M	-103.86M	62.06M	94.56M
Cash from Investing	-64.83M	-966.93M	-482.14M	46.58M	-137.98M	-220.46M	-214.23M	-219.01M
Capital Expenditures	-80.5M	-121.53M	-160.66M	-151.11M	-137.41M	-187.51M	-211.9M	-217.08M
CapEx % of Revenue	3.82%	4.05%	3.86%	2.95%	2.54%	3.14%	3.35%	-
Acquisitions	-2.5M	-857.55M	-349.83M	206.37M	0	-31.25M	-2.5M	-2.5M
Investments	-	-	-	-	-	-	-	-
Other Investing	18.17M	12.16M	28.35M	-8.69M	-575K	-1.71M	179K	580K
Cash from Financing	-25.89M	826.81M	353.22M	-270.33M	-102.26M	24.64M	-103.47M	-98.85M
Debt Issued (Net)	-5.67M	718.51M	252.63M	-16.41M	-7.03M	-104.77M	-7.99M	-10.24M
Equity Issued (Net)	0	143.94M	99.12M	0	0	208.66M	0	0
Dividends Paid	0	0	0	-174.81M	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0
Other Financing	-20.22M	-35.64M	1.47M	-79.11M	-95.24M	-79.24M	-95.48M	-88.6M
Net Change in Cash	-4.95M▲ 0%	-20.65M▼ 317.6%	-12.3M▲ 40.4%	-262.11M▼ 2031.3%	-18.55M▲ 92.9%	119.21M▲ 742.7%	152.82M▲ 28.2%	114.65M▲ 0%
Free Cash Flow	3.62M▲ 0%	-2.06M▼ 157.0%	-1.07M▲ 48.1%	-189.47M▼ 17590.6%	84.29M▲ 144.5%	127.52M▲ 51.3%	258.61M▲ 102.8%	213.81M▲ 0%
FCF Margin %	0.17%	-0.07%	-0.03%	-3.69%	1.56%	2.14%	4.09%	3.33%
FCF Growth %	-	-156.96%	48.06%	-17590.57%	144.49%	51.28%	102.8%	80.66%
FCF per Share	0.03	-0.01	-0.01	-1.32	0.59	0.96	1.83	1.83
FCF Conversion (FCF/Net Income)	5.87x	-3.35x	-1.12x	-0.20x	4.41x	1.50x	3.46x	1.59x
Interest Paid	26.01M	64.63M	86.54M	90.85M	81.61M	74.98M	0	0
Taxes Paid	23.62M	2.37M	5.55M	55.82M	19.43M	41.6M	0	0

ARDT Key Ratios

Ardent Health Partners, LLC (ARDT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2022	2023	2024	2025	TTM
Return on Equity (ROE)	-6.17%	-19.43%	21.44%	4.72%	16.15%	8.47%	8.02%
Return on Invested Capital (ROIC)	8.36%	6.32%	6.65%	5.71%	9.68%	7.53%	7.53%
Gross Margin	100%	100%	81.38%	97.4%	82.68%	97.54%	60.52%
Net Margin	-1.19%	-3.44%	3.68%	0.93%	3.53%	2.15%	2.09%
Debt / Equity	1.25x	1.77x	2.27x	2.21x	1.50x	1.34x	1.34x
Interest Coverage	1.72x	0.94x	4.80x	3.20x	6.54x	5.90x	6.36x
FCF Conversion	-3.35x	-1.12x	-0.20x	4.41x	1.50x	3.46x	1.59x
Revenue Growth	42.6%	38.63%	23.25%	5.45%	10.29%	6.01%	6.72%

ARDT SEC Filings & Documents

Ardent Health Partners, LLC (ARDT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 5, 2026·SEC

Material company update

Mar 27, 2026·SEC

Material company update

Mar 4, 2026·SEC

10-K Annual Reports

FY 2026

Mar 16, 2026·SEC

FY 2025

Feb 27, 2025·SEC

10-Q Quarterly Reports

FY 2026

May 6, 2026·SEC

FY 2025

Nov 14, 2025·SEC

FY 2025

Aug 6, 2025·SEC

ARDT Frequently Asked Questions

Ardent Health Partners, LLC (ARDT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Ardent Health Partners, LLC (ARDT) reported $6.43B in revenue for fiscal year 2025. This represents a 205% increase from $2.11B in 2016.

Ardent Health Partners, LLC (ARDT) grew revenue by 6.0% over the past year. This is steady growth.

Yes, Ardent Health Partners, LLC (ARDT) is profitable, generating $134.3M in net income for fiscal year 2025 (2.1% net margin).

Dividend & Returns

Ardent Health Partners, LLC (ARDT) has a return on equity (ROE) of 8.5%. This is below average, suggesting room for improvement.

Ardent Health Partners, LLC (ARDT) generated $213.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More ARDT

Ardent Health Partners, LLC (ARDT) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Ardent Health Partners, LLC(ARDT)Earnings, Financials & Key Ratios

ARDT Key Insights

✓Strengths

✗Weaknesses

ARDT Price & Volume

ARDT Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

ARDT Recent Earnings

ARDT Peer Comparison

Compare ARDT vs Peers

vs HCA

vs UNH

Compare Top 5

ARDT Income Statement

ARDT Balance Sheet

ARDT Cash Flow Statement

ARDT Key Ratios

ARDT SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

ARDT Frequently Asked Questions

Explore More ARDT

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation